Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection - Nature Chemical Biology

United Kingdom News News

Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection - Nature Chemical Biology
United Kingdom Latest News,United Kingdom Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

CRISPRtechnology demonstrates success in preventing and treating COVID nchembio

Human embryonic kidney 293T , 293FT and Vero-ACE2 cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 1% penicillin/streptomycin and 10% fetal bovine serum . Caco-2 cells were grown in DMEM supplemented with 1% penicillin/streptomycin and 20% FBS. Vero-ACE2 cells stably expressing TMPRSS2 were generated by transduction of Vero-ACE2 cells with a lentiviral vector expressing human TMPRSS2, followed by blasticidin S HCl selection for 7 d.

Primers were synthesized by IDT and their sequences are listed in Supplementary Tablemethod and the raw data was normalized by the internal controlRNA-seq analysis was carried out as previously described in ref.vectors in combination with a CasRx expression plasmid and incubated for 24 h. RNA was extracted using the RNeasy Mini Kit . For library preparation, mRNA was first enriched with NEBNext Poly mRNA Magnetic Isolation Module .

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Scientists explore immune memory of common cold coronaviruses before the SARS-CoV-2 pandemic eraScientists explore immune memory of common cold coronaviruses before the SARS-CoV-2 pandemic eraScientists explore immune memory of common cold coronaviruses before the SARS-CoV-2 pandemic era ljiresearch CommonCold ColdVirus SARSCoV2 COVID19 Pandemic ImmuneMemory
Read more »

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infectionResearchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infectionResearchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection Coronavirus Disease COVID Omicron NHSBartsHealth imperialcollege
Read more »

How SARS-CoV-2 Omicron spike mutations contribute to increased infectivityHow SARS-CoV-2 Omicron spike mutations contribute to increased infectivityHow SARS-CoV-2 Omicron spike mutations contribute to increased infectivity SARSCoV2 Omicron SpikeProtein COVID neutralization BA1 BA2 variant evolution cellhostmicrobe uni_ulm TheCrick
Read more »

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgASARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgASARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA medrxivpreprint vaxart COVID19 Vaccine OralVaccine Trial SARSCoV2
Read more »

Scientists identify papain-like protease inhibitor against COVID-19Scientists identify papain-like protease inhibitor against COVID-19In a new study, researchers identified a papain-like protease inhibitor for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.
Read more »

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infectionResearchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infectionResearchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection Coronavirus Disease COVID Omicron NHSBartsHealth imperialcollege
Read more »



Render Time: 2025-02-21 23:03:07